{
    "code": 0,
    "data": [
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of the Un-Audited financial results for the Quarter ended 31st December 2025 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 08th February 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d843de4c-9797-424d-9914-1c98ba7f867b.pdf",
            "news_date": "2026-02-08 17:02:30"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Completion Of United States Food And Drug Administration (USFDA) Inspection With No Form 483 Observations Issued",
            "news_body": "Completion of United States Food and Drug Administration (USFDA) Inspection with no Form 483 observations issued.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e41ffca-dc76-48d8-986d-8a5d6634ef8a.pdf",
            "news_date": "2026-02-06 19:46:45"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination Of Materiality Of Events.",
            "news_body": "Granting Authorization to Key Managerial Personnel for determination of materiality of events/ information under Regulation 30 (5) of SEBI (LODR) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78403fab-c83a-4bc3-9acc-03ecb0337a77.pdf",
            "news_date": "2026-02-06 19:30:09"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": " Results-Financial Results For December 31 2025",
            "news_body": "Unaudited Financial Results for the quarter ended 31st December 2025",
            "news_id": "a1304932-8620-4059-995e-6dd813e06994",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd82a7c8-7072-4b9c-9487-b8bbd502ad57.pdf",
            "news_date": "2026-02-06 19:02:54",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": " Results-Financial Results For December 31 2025",
            "news_body": "Unaudited Financial Results for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd82a7c8-7072-4b9c-9487-b8bbd502ad57.pdf",
            "news_date": "2026-02-06 19:02:54"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for  Board Meeting Outcome For The Board Meeting Held On 06/02/2026",
            "news_body": "To consider and approve the Un-audited Financial results along with Limited Review Report for the quarter ended 31st December 2025 and Granting Authorization to Key Managerial Personnel for determination of materiality of events/ information under Regulation 30(5) of SEBI (LODR) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d8b72fa-23df-4c3a-89e1-746667f6d709.pdf",
            "news_date": "2026-02-06 18:24:52"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St December 2025.",
            "news_body": "Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Unaudited Financial Results for the quarter ended 31st December 2025 and to consider any other matter with the permission of the Chairman.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40f4a0b4-dd98-49dd-882e-b83905e8a342.pdf",
            "news_date": "2026-02-02 15:50:46"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR)",
            "news_body": "Disclosure Under Regulation 30 of the SEBI LODR regarding Assessment Order received under Section 143(3) read with Section 263 and 144B of the Income Tax Act 1961.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7c7db9c-ea09-4658-bb07-6a03526fc032.pdf",
            "news_date": "2026-01-21 15:38:54"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2025 received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=511b0630-2076-4aed-995d-0cf1aa013e7a.pdf",
            "news_date": "2026-01-12 15:33:22"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Updates",
            "news_body": "Approval from EDQM for CEP of Sulfadimethoxine.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=681117e1-c8cd-4cc6-8f08-12af7a4a9b1b.pdf",
            "news_date": "2025-12-05 11:31:38"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY 2025-26",
            "news_id": "dd087845-517c-4dc2-8969-d4ab74a9dc7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cd8b518-8788-471a-9560-fd08aa047c87.pdf",
            "news_date": "2025-11-17 18:39:17",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cd8b518-8788-471a-9560-fd08aa047c87.pdf",
            "news_date": "2025-11-17 18:39:17"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of the Un-Audited financial results for the Quarter and Half year ended 30th September 2025 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 09th November 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9523337-3dee-4d05-8b81-847e30fbf8f8.pdf",
            "news_date": "2025-11-09 14:16:58"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Adoption Of Revised Polices And Codes",
            "news_body": "Adoption of Revised Policies and Codes",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42684b6d-4daa-4461-8342-b85d94ae7d0c.pdf",
            "news_date": "2025-11-07 18:53:18"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For September 30 2025",
            "news_body": "Unaudited Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "2600fc84-5a44-47de-980b-98ac7a3ddfea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c877560-ad45-4116-81f1-5be0ad72b1bb.pdf",
            "news_date": "2025-11-07 17:25:28",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results-Financial Results For September 30 2025",
            "news_body": "Unaudited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c877560-ad45-4116-81f1-5be0ad72b1bb.pdf",
            "news_date": "2025-11-07 17:25:28"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/11/2025",
            "news_body": "To consider and approve the Un-audited Financial results along with Limited Review Report for the quarter and half year ended 30th September 2025 and Adoption of revised policies of the company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=768b1d8d-5686-4ce5-b885-547ae1833fb1.pdf",
            "news_date": "2025-11-07 17:13:41"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025.",
            "news_body": "Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2025 and to consider any other matter with the permission of the Chairman.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99ca8b50-4441-420e-8028-ee801206c51b.pdf",
            "news_date": "2025-10-31 18:58:22"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate pursuant to Regulation 74 (5) of SEBI (Depositories and  Participants) Regulations 2018 for the quarter and half year ended 30th September 2025 received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0249ac34-42d5-4eda-bdc8-3c98b8925d93.pdf",
            "news_date": "2025-10-10 16:15:06"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding the closure of Trading Window for dealing in securities of the company shall remain closed from Wednesday 01st October 2025 till the expiry of 48 hours after the declaration of Un-audited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b794504f-2f88-4142-aca1-22300ae96f42.pdf",
            "news_date": "2025-09-26 17:06:09"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for transfer of equity shares of the Company for which Dividend has not been claimed by shareholders for seven consecutive years or more to Investor Education and Protection Fund (IEPF) published in Financial Express (English) and Mumbai Lakshdeep (Marathi).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fb05fc0-2e1e-4051-bd02-c5e12a82a32b.pdf",
            "news_date": "2025-09-26 13:09:30"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation of Reaffirmation of Credit Ratings by ICRA Credit Rating Limited under Regulation 30 of SEBI (LODR) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d880ba7-623e-462e-af19-bf49801cde8b.pdf",
            "news_date": "2025-09-16 12:10:22"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for 100 days Campaign - \"Saksham Niveshak.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74dad4c9-07c4-4ad4-8568-364952d6e4d8.pdf",
            "news_date": "2025-09-11 14:44:47"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication regarding notice to shareholders for special window for re-lodgment of transfer request for physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=393cde97-9e89-427a-89b1-8ec8a085010c.pdf",
            "news_date": "2025-09-09 16:04:33"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Disclosure under Regulation 30 of SEBI (LODR) 2015 regarding Change in Management.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f676f2bc-a28c-497f-86fa-e1c27bb01e5d.pdf",
            "news_date": "2025-08-26 20:06:07"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 - General Updates",
            "news_body": "Disclosure of Announcement under Regulation 30 of SEBI (LODR) 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98ea1d32-630a-4a2d-bcce-6df12bbb8eb3.pdf",
            "news_date": "2025-08-26 20:03:57"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Submission of Scrutinizer Report and Voting Results for the 65th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8810e01-15ef-46c2-a65f-a15717eb853b.pdf",
            "news_date": "2025-08-26 19:17:39"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome of the 65th Annual General Meeting of Anuh Pharma Limited held on Friday 22nd August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d02de6f0-725a-4ab6-86a3-342ce166d281.pdf",
            "news_date": "2025-08-22 18:40:27"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q1 FY 2025-26",
            "news_id": "d95dabd9-1170-4ac5-8268-7c791e76fe32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0fa3838-c22a-4161-a752-fd07d6dfeea1.pdf",
            "news_date": "2025-08-22 13:34:48",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q1 FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0fa3838-c22a-4161-a752-fd07d6dfeea1.pdf",
            "news_date": "2025-08-22 13:34:48"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding 100 Days Campaign - Saksham Niveshak",
            "news_body": "Intimation Regarding 100 Days Campaign - Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b203d0b9-1f29-4b4a-9b76-2939b6570189.pdf",
            "news_date": "2025-08-20 18:14:34"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of the Un-Audited financial results for the Quarter ended 30th June 2025 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 09th August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fecb7b78-36f7-4ded-a9e0-570c086c7cb6.pdf",
            "news_date": "2025-08-09 17:32:17"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Chief Marketing Officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1f35f74-f0c9-436e-aa9a-52570aadca21.pdf",
            "news_date": "2025-08-08 18:17:37"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter ended 30th June 2025",
            "news_id": "f2d96226-0af4-4431-9c76-9428752be016",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91f17f6e-9c19-410d-b1d3-7ca6d21e056a.pdf",
            "news_date": "2025-08-08 18:12:47",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results-Financial Results For June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91f17f6e-9c19-410d-b1d3-7ca6d21e056a.pdf",
            "news_date": "2025-08-08 18:12:47"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome For The Board Meeting Held On 08/08/2025",
            "news_body": "To consider and approve the Un-audited Financial results along with Limited Review Report for the quarter ended 30th June 2025 and appointment of Chief Marketing Officer of the company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41e34094-fdee-4101-b247-1c8bb140e9c2.pdf",
            "news_date": "2025-08-08 17:13:33"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2025.",
            "news_body": "Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve unaudited financial results for the quarter ended 30th June 2025 and to consider any other matter with the permission of the Chairman.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22f758b4-9d2b-4bb2-b57b-3e287d9e5e06.pdf",
            "news_date": "2025-08-01 16:05:24"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "In furtherance to our Disclosure under Regulation 30 for Newspaper Publication for the Notice of 65th Annual General Meeting Book Closure & E-voting Information being published on 29th July 2025 please find enclosed herewith the newspaper cutting for the corrigendum published in Mumbai Lakshdeep (Marathi Language) on 30th July 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fac95077-9fd3-4837-a3d1-72b4603f33c8.pdf",
            "news_date": "2025-07-30 17:01:03"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting - Rectified Covering Letter For Notice Of Annual General Meeting On Friday 22Nd August 2025",
            "news_body": "In continuation with the earlier intimation being made on Exchange on 29/07/2025 please find attached the rectified covering letter along with Notice of 65th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b4cace1-7f4f-4727-9c57-0b533e6c7190.pdf",
            "news_date": "2025-07-29 18:19:44"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Corporate Action - Fixes Revised Record Date For Dividend And Annual General Meeting",
            "news_body": "The Revised Record for the Dividend and Annual General Meeting is fixed and the same is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f50ab449-0387-4a90-84d3-114e607f4df8.pdf",
            "news_date": "2025-07-29 14:26:29"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General Updates",
            "news_body": "This is to inform to the stock exchange regarding dispatch of physical communication to shareholders who have not registered their email address.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a34db39-e4a1-4e64-9283-00e5732e4549.pdf",
            "news_date": "2025-07-29 14:13:45"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a meeting of the Shareholders of the Company will be held on Friday 22nd August 2025 at Mumbai please find enclosed Newspaper Clipping of the Advertisement published on Tuesday 29th July 2025 in the Financial Express (English) and Mumbai Lakshdeep (Marathi) Mumbai Edition.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c4258ae-983d-4d17-ab0d-cf867900a94c.pdf",
            "news_date": "2025-07-29 13:40:34"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Pursuant to the provisions of Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the copy of Annual Report of the Company for the financial year 2024-25 of the Company for your information and records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcdc1047-50c6-45dc-98cf-96ec96cd0955.pdf",
            "news_date": "2025-07-29 13:30:24"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting - Annual General Meeting On Friday 22Nd August 2025",
            "news_body": "In terms of the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith a copy of the Notice of the 65th Annual General Meeting of the Company to be held on Friday 22nd August 2025 at 04:00 PM at Hall of Harmony Nehru Centre Dr. Annie Besant Road Worli Mumbai-400018 Maharashtra India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccbf801e-53c0-4390-be60-4035a613c4ef.pdf",
            "news_date": "2025-07-29 13:01:24"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification Sought From Anuh Pharma Ltd",
            "news_body": " Please find attached the clarification on Spurt in volume.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b53ac29c-b827-4a2c-8835-63241413407b.pdf",
            "news_date": "2025-07-22 13:36:43"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Anuh Pharma Ltd",
            "news_body": "The Exchange has sought clarification from Anuh Pharma Ltd on July 22 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-07-22 12:55:32"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Disclosure regarding allotment of 50112000 equity shares pursuant to Bonus issue.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6aab6c48-4190-49cd-bc91-c632f050b17b.pdf",
            "news_date": "2025-07-16 11:23:29"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Inauguration Of Manufacturing Block INT 1A Of The Company.",
            "news_body": "This is to inform that the company has inaugurated its new manufacturing Block INT 1A at E-17/3 E-17/4 & E-18 M.I.D.C. Tarapur Boisar Dist Palghar - 401506 India on 15th July 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e03091eb-ff50-4718-9d24-db8d641774f3.pdf",
            "news_date": "2025-07-15 14:50:23"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Enclosed herewith is the Voting Results and Scrutinizer Report for Postal Ballot Notice dated 23rd May 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a6d92c6-845d-493b-90f6-970d52de5da3.pdf",
            "news_date": "2025-07-08 17:29:27"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30th June 2025 received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of the company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48bf271b-3607-4eec-9d70-41c4a3a197e2.pdf",
            "news_date": "2025-07-08 17:08:23"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Corporate Action - Record Date For Issue Of Bonus Equity Shares Of The Company.",
            "news_body": "The Company has fixed Tuesday 15th July 2025 as the \"Record Date\" for the purpose of issuance of Bonus Shares of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef635228-50e6-4f53-9db5-1d4c010eec28.pdf",
            "news_date": "2025-07-07 17:48:01"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding the closure of Trading Window for dealing in securities of the company shall remain closed from Tuesday 01st July 2025 till the expiry of 48 hours after the declaration of Un-audited Financials Results for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0dabd652-32ed-4641-a2b9-10639c03559a.pdf",
            "news_date": "2025-06-26 16:59:15"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for Completion of dispatch of Postal Ballot Notice",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55c8fd13-1ac4-4a78-af7c-7050cd1bffa6.pdf",
            "news_date": "2025-06-07 15:58:59"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of Postal Ballot for Issue of Bonus Shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f9ab5d9-2f31-41ac-8153-2a653404e1f2.pdf",
            "news_date": "2025-06-06 16:43:37"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4 FY 2024-25",
            "news_id": "9bf86f04-b02f-4553-9fa8-4f84576b5563",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d24cdc7-ab86-4104-8bd6-4542bd315f0c.pdf",
            "news_date": "2025-05-29 16:47:40",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4 FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d24cdc7-ab86-4104-8bd6-4542bd315f0c.pdf",
            "news_date": "2025-05-29 16:47:40"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Corporate Action - Fixes Record Date For Dividend And Annual General Meeting",
            "news_body": "The Record Date for the Dividend and Annual General Meeting is fixed and the same is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb3c3bbd-0ad7-458e-a907-df459c877e26.pdf",
            "news_date": "2025-05-28 16:44:53"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2d13634-5bc3-447f-a543-9707bc198fa5.pdf",
            "news_date": "2025-05-27 17:58:40"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of the Audited Financial results for the quarter and year ended 31st March 2025 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 25th May 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a25cef0f-3c9b-460e-853f-077848657124.pdf",
            "news_date": "2025-05-25 12:50:21"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)",
            "news_body": "Adoption of Revised Policies",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0216342-9ae8-437d-b5a7-7138776c84d9.pdf",
            "news_date": "2025-05-23 22:15:01"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)",
            "news_body": "Intimation for re-appointment of Joint Managing Directors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d4bc7de-5185-4ab2-bd3e-6bd9aab2bbf0.pdf",
            "news_date": "2025-05-23 22:13:11"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)",
            "news_body": "Intimation for Re-appointment of Directors retiring by rotation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b76c47fa-5c16-454c-876c-58a40cadee47.pdf",
            "news_date": "2025-05-23 22:10:18"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)",
            "news_body": "Re-appointment of Internal Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c338bafa-4677-4175-a428-eb6e72c95306.pdf",
            "news_date": "2025-05-23 22:06:26"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)",
            "news_body": "Re-appointment of Cost Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0dfa0fb4-5dc4-4248-a761-2089e95bb0a0.pdf",
            "news_date": "2025-05-23 22:04:48"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) Appointment Of Secretarial Auditors",
            "news_body": "Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6133b07f-3b6b-4a61-9cc9-a936f2b53d21.pdf",
            "news_date": "2025-05-23 22:02:03"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Bonus",
            "caption": "Corporate Action-Board recommends Bonus Issue",
            "news_body": "Bonus issue of 1 fully paid up Equity shares for every 1 fully paid up existing shares of the company i.e. 1:1.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3912d6fa-12b8-4b1f-8304-2368e9504cb3.pdf",
            "news_date": "2025-05-23 21:55:54"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Final Dividend of Rs. 1.50 (30%) per equity shares of Face Value of Rs. 5 each for the Financial Year ended 31/03/2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4597aec2-976b-4bd0-a0f5-6117ccb4c70a.pdf",
            "news_date": "2025-05-23 21:52:25"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Results - Financial Results For March 31 2025 (Quarter And Year Ended 31/03/2025)",
            "news_body": "Revised Audited Financial Results for quarter and year ended 31st March 2025",
            "news_id": "0cc7ffb6-ee9a-4dfd-9c4d-e12883453fd2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e4ca45b-0d9a-49b2-bcb3-01269799dcc1.pdf",
            "news_date": "2025-05-23 21:10:10",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Revised Results - Financial Results For March 31 2025 (Quarter And Year Ended 31/03/2025)",
            "news_body": "Revised Audited Financial Results for quarter and year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e4ca45b-0d9a-49b2-bcb3-01269799dcc1.pdf",
            "news_date": "2025-05-23 21:10:10"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Revision of outcome",
            "caption": "Board Meeting Outcome for Revised Outcome For The Board Meeting Dated 23/05/2025",
            "news_body": "Revised outcome to consider and approve the Audited Financial Results for the Financial Year ending 31st March 2025 issue of Bonus Equity shares in the ration of 1:1 i.e. 1 (One) equity shares of ? 5.00/- each for every 1 (One) full paid-up equity share of ? 5.00/- recommendation of Dividend for the Financial Year 2024-25 subject to the approval of the members.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f94229fc-8cb1-4684-bafe-c1f89c9b7e32.pdf",
            "news_date": "2025-05-23 20:59:58"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financials Results For The Year Ended 31/03/2025",
            "news_body": "Financials results",
            "news_id": "fb245662-a62a-4bf6-9ee5-e207bdea5c7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27b8ae44-5952-4478-a901-24e49efd8700.pdf",
            "news_date": "2025-05-23 20:38:31",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results - Financials Results For The Year Ended 31/03/2025",
            "news_body": "Financials results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27b8ae44-5952-4478-a901-24e49efd8700.pdf",
            "news_date": "2025-05-23 20:38:31"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 23/05/2025",
            "news_body": "To consider and approve the Audited Financial Results for the Financial Year ending 31st March 2025 issue of Bonus Equity shares in the ration of 1:1 i.e. 1 (One) equity shares of ? 5.00/- each for every 1 (One) full paid-up equity share of ? 5.00/- recommendation of Dividend for the Financial Year 2024-25 subject to the approval of the members.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fe6019a-3ee3-4940-8922-62029538dab7.pdf",
            "news_date": "2025-05-23 19:49:50"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Financial Year Ended 31St March 2025 Proposal Of Bonus Issue If Any And Subject To Approval And Recommendation Of Final Dividend If Any For The Financial Year 202",
            "news_body": "Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve Audited Financial Results for the Quarter and Financial Year ended 31st March 2025 proposal of Bonus Issue if any and subject to approval and recommendation of Final Dividend if any for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db294769-331f-4c5b-b29d-4d21d77394f0.pdf",
            "news_date": "2025-05-19 14:36:49"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Anuh Pharma Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230MH1960PLC011586</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Manan Vadhan <br/>  Designation: Company Secretary and Compliance Officer <br/> EmailId: aplcs@sk1932.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Darshan Rampariya <br/> Designation: Chief Financial Officer <br/> EmailId: darshan.r@anuhpharma.com</div> </div> <div> <br/> Date: 28/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e44325d7-24a8-4b85-ad21-05a7d2c2edb9.pdf",
            "news_date": "2025-04-28 16:49:38"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March 2025 received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of our company. We request you to kindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbb7d358-a42d-498c-b00b-133cf29e52ed.pdf",
            "news_date": "2025-04-08 18:00:56"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding the Closure of Trading Window for dealing in securities of the company shall remain closed from Tuesday 01st April 2025 till the expiry of 48 hours after the declaration of Audited Financial Results for the year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e47886e9-fa12-4b0d-8310-6bdf7a00a3ae.pdf",
            "news_date": "2025-03-26 15:57:16"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Non-Applicability Of Statement Of Deviation(S) And Variation(S) Under Regulation 32(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Non-applicability of Statement of Deviation(s) and Variation(s) under Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=131a1e7c-a58c-4213-8966-0b8719df7d59.pdf",
            "news_date": "2025-02-13 16:47:07"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "In furtherance to our Disclosure under Regulation 30 for Newspaper Publication for Unaudited Financial Results for the quarter ended 31st December 2024 being published on 09th February 2025 please find enclosed herewith the newspaper cutting for the corrigendum published in Mumbai Lakshdeep (Marathi Language) on 11th February 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4991603-5f4f-46f5-8350-2fe7bf1f53d7.pdf",
            "news_date": "2025-02-11 14:48:17"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of the Un-audited financial results for the quarter ended 31st December 2024 published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi language on 09th February 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c125972d-2155-4ff2-90d6-9f15600e717d.pdf",
            "news_date": "2025-02-09 12:42:37"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financial) for the Quarter ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba62face-0195-41ef-88d4-abfa83701c36.pdf",
            "news_date": "2025-02-07 18:32:57"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For December 31 2024 (Quarter Ended 31St December 2024)",
            "news_body": "Un-Audited Financial Results for the Quarter ended 31st December 2024",
            "news_id": "6b4e36a1-bc4e-4189-a3a1-63377fb0dc9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7f39d8d-1e6b-4316-8da2-f41c61cf0f4e.pdf",
            "news_date": "2025-02-07 18:01:41",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results - Financial Results For December 31 2024 (Quarter Ended 31St December 2024)",
            "news_body": "Un-Audited Financial Results for the Quarter ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7f39d8d-1e6b-4316-8da2-f41c61cf0f4e.pdf",
            "news_date": "2025-02-07 18:01:41"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 07Th February 2025",
            "news_body": "To consider and approve the Un-audited Financial Results and Limited Review Report for the Quarter ended 31st December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b091eb01-ad16-4f69-9549-84f3416c73fc.pdf",
            "news_date": "2025-02-07 17:40:56"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve unaudited financial results for the quarter ended 31st December 2024 and to consider any other matter with the permission of the Chairman.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a1a58c6-9967-404c-8d15-02c4936d7b49.pdf",
            "news_date": "2025-01-31 17:05:47"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2024 received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of our company. We request you to kindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1825e0b-c05f-4882-9962-99bff6bf86bc.pdf",
            "news_date": "2025-01-13 17:15:50"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for transfer of equity shares of the Company for which Dividend has not been claimed by shareholders for seven consecutive years or more to Investor Education and Protection Fund (IEPF) published in Financial Express (English) and Mumbai Lakshadeep (Marathi).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=647c72a5-d0bb-4050-afbe-9d12831d819c.pdf",
            "news_date": "2024-12-28 18:36:03"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "As per attached Representation for Withdrawal of fines and penal action initiated by your good office, we request you to kindly take note that we are in compliance with the Regulation 18(1) of SEBI (LODR), 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea2d7ee0-ca0f-4039-b4d7-bacc96d7c468.pdf",
            "news_date": "2024-12-02 17:34:34"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY2024-25",
            "news_id": "e09836b3-b124-4971-a940-3c00d73cdff7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f259f5b3-39f4-4e71-bcd0-c8625d4cfd9e.pdf",
            "news_date": "2024-11-29 16:59:27",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f259f5b3-39f4-4e71-bcd0-c8625d4cfd9e.pdf",
            "news_date": "2024-11-29 16:59:27"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to our letter dated 31st May, 2024, informing that Anuh Pharma Limited had signed a definitive agreement to subscribe for the equity share capital in Huoban Energy 5 Private Limited. It is hereby informed that the Company has completed its subscription in equity share capital of Huoban Energy 5 Private Limited on 26th November, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4244f64f-5514-47d3-9278-7c6c007febeb.pdf",
            "news_date": "2024-11-26 17:24:47"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Inaugration Of Plant 3 Of The Company",
            "news_body": "This is to inform that the Company has inaugrated its new Plant API-3 at E-17/3, E-17/4 & E-18, M.I.D.C., Tarapur, Biosar, Dist Palghar - 401506, India on 15th November, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5aee8d27-f7a5-4cd2-a97f-2bb66fd51846.pdf",
            "news_date": "2024-11-15 18:24:46"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "In furtherance to our Disclosure under Regulation 30 for Newspaper publication for Unaudited Financial Results for the Quarter and half year ended 30th September, 2024 being published on 09th November, 2024, please find enclosed herewith the newspaper cutting of the corrigendum published in Mumbai Lakshdeep (Marathi Language) on 15th November, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e181e54-d450-480d-838d-c8b6e836fd1d.pdf",
            "news_date": "2024-11-15 17:36:11"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "Reg. 32 (1), (3) - Statement of Deviation & Variation",
            "caption": "Non-Applicability Of Statement For Deviation(S) Or Variation(S) Under Regulation 32 (1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Non-Applicability of Statement for Deviation(s) or Variation(s) under Regulation 32 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a51c743-2fe7-4d4e-8318-0ac1fcf5a13c.pdf",
            "news_date": "2024-11-14 16:42:26"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of the Un-audited financial results for the quarter and half year ended 30th September, 2024, published in the Financial Express in English language and Mumbai Lakshdeep in Marathi language on 09th November, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36a7d98e-3862-427c-9efe-68d61b8b01d2.pdf",
            "news_date": "2024-11-09 11:37:13"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For September 30, 2024",
            "news_body": "Un-audited Financial Results along with Limited Review Report for the Quarter and Half Year ended September 30, 2024.",
            "news_id": "88457964-08bd-470c-86da-097cd97b294e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4617e7e6-9a5c-4b5c-bd4a-63dc76251b29.pdf",
            "news_date": "2024-11-08 16:56:54",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Results - Financial Results For September 30, 2024",
            "news_body": "Un-audited Financial Results along with Limited Review Report for the Quarter and Half Year ended September 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4617e7e6-9a5c-4b5c-bd4a-63dc76251b29.pdf",
            "news_date": "2024-11-08 16:56:54"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 08Th November, 2024",
            "news_body": "To consider and approve the Un-audited Financial results and Limited Review Report for the Quarter and half year ended 30th September, 2024 and approving the revised Policy for Prevention of Sexual Harassment (POSH) at Workplace as per The Sexual Harassment of Women at Workplace (Prevention, Prohibition and; Redressal) Act, 2013 ('Act').",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ee22636-2145-4c4d-93f2-c5bb02fe592c.pdf",
            "news_date": "2024-11-08 16:50:22"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024",
            "news_body": "ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended 30th September, 2024 and to consider any other matter with the permission of the Chairman.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=533abaf7-49a0-4842-989c-03e33da9548c.pdf",
            "news_date": "2024-10-29 17:35:00"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2024 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) of our Company. We request you to Kindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=864f570a-4e4c-4f60-99ea-0f94a411624e.pdf",
            "news_date": "2024-10-07 17:18:57"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)-Updates",
            "news_body": "Approval from EDQM for CEP of Allopurinol API which is used to treat Gout and High Uric Acid Levels.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07409ec0-90a8-4890-ab7b-97f28c8d1036.pdf",
            "news_date": "2024-09-26 17:48:03"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding the Closure of Trading Window for dealing in securities of the company shall remain closed from Tuesday, 01st October, 2024 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the Quarter and half year ended 30th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f27028b-73ff-44a8-9758-8482eb61929f.pdf",
            "news_date": "2024-09-26 16:53:51"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication for corrigendum to Annual Report of the 64th Annual General Meeting for the FY 2023-24 of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3943e22a-2247-407e-a63e-b460a3a03805.pdf",
            "news_date": "2024-09-08 16:29:42"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "In Continuation to the Annual Report filed with BSE dated 30/07/2024, the corrigendum to Annual Report of the 64th Annual General Meeting of the Company is been enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b6c5157-dc51-4e7c-a370-416fa9f4ee3e.pdf",
            "news_date": "2024-09-08 16:26:45"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bijal Kaushal Shroff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6DFAD362_D7DA_427C_93BD_066DB31B383E_110639.pdf",
            "news_date": "2024-09-04 11:06:42"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bijal Kaushal Shroff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85009FBD_9DC4_47EC_8CE5_292965443851_122344.pdf",
            "news_date": "2024-09-04 11:02:36"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.",
            "news_body": "This is to inform that with reference to the above subject, we have received intimation from Mrs. Bijal Kaushal Shroff under regulation 29(2) of SEBI (SAST) Regulations, 2011",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f7cf96b-b889-478b-bd44-b50a21685e2e.pdf",
            "news_date": "2024-09-03 18:42:19"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure As Per Regulation 7(2) And 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.",
            "news_body": "Pursuant to Regulation 7(2) and 6(2) of SEBI (PIT) Regulations, 2015 (PIT Regulations), we are enclosing herewith the disclosures received by the Company from Designated Person of the Company in Form C with respect to sale of Equity Shares of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd57ef3e-4fb9-439e-a2f0-a8c317bfed7b.pdf",
            "news_date": "2024-09-03 18:40:10"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.",
            "news_body": "This is to inform that with reference to the above subject, we have received intimation from Mrs. Bijal Kaushal Shroff under regulation 29(2) of SEBI (SAST) Regulations, 2011",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcdb6626-83d9-40d8-9d62-a556cfe55aae.pdf",
            "news_date": "2024-09-03 18:29:50"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure As Per Regulation 7(2) And 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.",
            "news_body": "Pursuant to Regulation 7(2) and 6(2) of SEBI (PIT) Regulations, 2015,  (PIT Regulations), we are enclosing herewith the disclosures received by the Company from Designated Person of the Company in Form C with respect to sale of Equity Shares of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2774a425-1882-4d65-95c0-b016ba497a49.pdf",
            "news_date": "2024-09-03 18:22:14"
        },
        {
            "co_code": 2916,
            "bse_code": 506260,
            "isin": "INE489G01022",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bijal Kaushal Shroff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E6D89C0A_990B_4DA3_82E9_543568782F7B_145236.pdf",
            "news_date": "2024-09-03 14:52:41"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results June 30, 2024 (Quarter Ended)",
            "news_body": "Financial Results for the Quarter ended June, 2024",
            "news_id": "83be4030-614d-4635-b6ef-4a9b18363bdd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a511d49f-05c4-404f-af5f-ee4fc3e39cab.pdf",
            "news_date": "2024-08-09 18:06:15",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Year Ended 31St March, 2024",
            "news_body": "Results for Financial year ended 31st March, 2024",
            "news_id": "ea2f40ba-cb21-4783-9cb7-6c3fb853e784",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0edc406-befe-4542-abcd-7cc69964873e.pdf",
            "news_date": "2024-05-17 18:59:38",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation For Q3 2024.",
            "news_id": "9f4ead8f-8ff7-4401-842a-50d978cac638",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=755e16c4-f9ee-4d98-a151-12ca400c144e.pdf",
            "news_date": "2024-02-19 11:37:15",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 31.12.2023",
            "news_body": "Unaudited Financial Results for the quarter ended 31.12.2023",
            "news_id": "b846baef-86c4-4b3e-ae59-e1bb7c5c3958",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d951d028-b3f3-4170-a371-9032fc2d1926.pdf",
            "news_date": "2024-02-09 16:32:06",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For September 30, 2023",
            "news_body": "Financial Results for the quarter ended 30th September, 2023",
            "news_id": "4556ac96-e487-4c9e-ac2e-fbfce4a1eb54",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d187d2a1-4aec-4820-ab37-3241ad15449e.pdf",
            "news_date": "2023-11-10 16:37:09",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Q1-2024.",
            "news_id": "deb9251c-a959-4d65-ba80-266519e461ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9146a94c-6b49-4f23-b104-2656ef250427.pdf",
            "news_date": "2023-08-21 15:29:36",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For June 30, 2023.",
            "news_body": "Results-Financial Results for June 30,2023.",
            "news_id": "631842c2-3309-42d0-b660-7bb19a906c7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0def3c8-06a4-4942-81cf-08a63ab748a1.pdf",
            "news_date": "2023-08-11 16:31:56",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Dear Sir/Madam,We are enclosing herewith our Company's Investor Presentation for the month of June, 2023.Kindly take the same on record.",
            "news_id": "92a9afdb-8ccf-4814-bb2a-a84924daec6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adf6c347-e68a-427a-89ea-0a98fd957196.pdf",
            "news_date": "2023-06-03 18:59:12",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For March 31, 2023.",
            "news_body": "Results-Financial Results for March 31, 2023.",
            "news_id": "4bd5fe0d-624c-479b-b057-8266a378fdc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=835aa7eb-caca-4772-ab70-0d9bb2b3df91.pdf",
            "news_date": "2023-05-19 16:38:14",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 19Th May, 2023",
            "news_body": "Outcome of Board Meeting dated 19th May, 2023",
            "news_id": "7d1da2cb-fd16-4d35-bda9-482b8b792efe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fb8b4cc-e993-440a-bc04-3bf160f15323.pdf",
            "news_date": "2023-05-19 16:28:24",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 FY2023Dear Sir/Madam,We are enclosing herewith our Company's Investor Presentation for Q3 FY2023.Kindly take the same on record.Thanking you,",
            "news_id": "74eb5e02-30e6-4bac-8fa1-1ef05109a788",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f51402ec-a09d-424d-9734-8982de6ed497.pdf",
            "news_date": "2023-02-17 15:24:38",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter Ended December 31, 2022 Along With Limited Review Report.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing herewith the following:<BR> <BR> 1. Unaudited Financial Results for the quarter ended December 31, 2022; and<BR> <BR> 2. Limited Review Report for the quarter ended December 31, 2022.<BR> <BR> You are requested to kindly take the same on record.  <BR> <BR>",
            "news_id": "9fb8b67e-47c1-47bd-b4cb-a0f6ff50df90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddb59cbe-18a6-4f1d-a7f8-c09a0e83dacb.pdf",
            "news_date": "2023-02-10 16:48:34",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 10Th February, 2023.",
            "news_body": "Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Friday, 10th February, 2023, inter-alia considered and approved the following agenda Items:<BR> <BR> 1. The Un-Audited Financial Results along with Limited Review Report thereon for the quarter ended 31st December, 2022. <BR> 2. The Board has approved the Resignation of Mr. Lalitkumar P Shah from the post of Director of Anuh Pharma Limited with immediate effect.<BR> <BR> The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 4:15 p.m<BR>",
            "news_id": "0b556ec5-33ae-470e-ad11-ecc5e4d84522",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce5174b9-9c90-4a86-b4b1-e7ebf53d6f5e.pdf",
            "news_date": "2023-02-10 16:33:31",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular bearing reference no.  SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 30th  September, 2022.Submitted for your information and records.",
            "news_id": "5865587b-81ef-4bfd-a267-06b75c1728fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f010591b-f809-42b3-99f8-e33aaa4a4cb1.pdf",
            "news_date": "2022-11-15 13:38:28",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter Ended              September 30, 2022 Along With Limited Review Report",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended,  we are enclosing herewith the following:1. Unaudited Financial Results for the quarter ended September 30, 2022; and2. Limited Review Report for the quarter ended September 30, 2022",
            "news_id": "9adfa23b-aa0c-40fb-bad3-e615f66d4c3d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68ed0960-9832-4fdb-9493-930a1d582bd0.pdf",
            "news_date": "2022-11-07 15:46:08",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 7Th November, 2022",
            "news_body": "Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Monday, 7th November, 2022, inter-alia considered and approved the following agenda Items: <BR> <BR> 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th September, 2022. <BR> <BR> <BR> The Meeting of the Board of Directors commenced at 12:30 PM and concluded at 3:15 PM<BR>",
            "news_id": "fb4b361d-7066-4d2a-a94f-56583d22f1de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0f4dbca-2829-4b43-8de7-da0025085958.pdf",
            "news_date": "2022-11-07 15:32:40",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are enclosing herewith our Company's Investor Presentation for Q1 FY2023.",
            "news_id": "227253ef-6c0c-4b49-a936-c9accbe02f55",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0411809c-4a6a-4c7c-91c0-85d0bda50783.pdf",
            "news_date": "2022-08-09 12:11:47",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2022 Along With Limited Review Report",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Unaudited Financial Results for the quarter ended June 30, 2022; and<BR> <BR> 2. Limited Review Report for the quarter ended June 30, 2022.<BR> <BR> <BR>",
            "news_id": "e9dc433b-c8f2-42e8-895f-4b421c693fbb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b17d0256-1463-4255-8650-513f4217e104.pdf",
            "news_date": "2022-08-05 14:31:30",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 5Th August, 2022",
            "news_body": "Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Friday, 5th August, 2022, inter-alia considered and approved the following agenda Items: <BR> <BR> 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th June, 2022. <BR>",
            "news_id": "715e5278-6b50-4efc-bf1f-f8af545b3bb1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92d2e86d-c36a-4337-8255-4cb05ce1668b.pdf",
            "news_date": "2022-08-05 14:27:27",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Earnings Audio Conference Call held on Monday, 30th May, 2022 at 4.30 PM wherein Financial Performance for Quarter and year ended 31st March, 2022 was discussed.",
            "news_id": "5a7729d7-6639-4e00-a5d9-9f71ec0419b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a571334-c387-4798-b0cc-15e89ab88fa6.pdf",
            "news_date": "2022-05-31 17:44:49",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of The Earnings Conference Call",
            "news_body": "Pursuant to Regulations 30 and 46(2)(ao)  of  SEBI  (Listing  Obligations  and  Disclosure  Requirements) Regulations,  2015, and  with  reference  to  the  subject  cited, please note  that  the  audio recording  of  the  Q4  FY  2022.",
            "news_id": "c08f1067-f797-458a-8e0f-2f3629d1dea0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77970918-d14e-423a-b422-d2d23b05639f.pdf",
            "news_date": "2022-05-30 18:31:24",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular bearing reference no.  SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 31st March, 2022.",
            "news_id": "e1dbb871-03ca-4464-8925-6bd4160638cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6b34475-1538-4a75-87e9-4c9ff04257ca.pdf",
            "news_date": "2022-05-27 17:37:02",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company''s Investor Presentation for the month of May, 2022.",
            "news_id": "d26a80a4-523b-4994-98a7-d6d2f4724d5a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5765d5d-1c06-4d1f-96dd-ed05c590f54f.pdf",
            "news_date": "2022-05-18 18:33:19",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised  Submission Of Audited Financial Results Along With Auditor''s Report For The Year Ended March 31, 2022 & Declaration",
            "news_body": "With reference to our previous submission dated 14th May, 2022, please find enclosed herewith our revised submission of Audited Financial Results along with Auditor's Report for the year ended 31st March, 2022 & Declaration from Joint Managing Directors w.r.t. Audit Report with unmodified opinion to the Audited Financial Results for the financial year ended 31st March, 2022. <BR> <BR>",
            "news_id": "8e585000-0d05-41d4-873f-8c3238aea5db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55c852de-94c8-4990-bc26-6d44b9461d4b.pdf",
            "news_date": "2022-05-16 18:07:40",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results Along With Auditor''s Report For The Year Ended March 31, 2022 & Declaration.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Audited Financial Results for the quarter & year ended March 31, 2022; and<BR> <BR> 2. Auditor''s Report on quarterly financial results and year to date results for the year ended 31st March, 2022; and<BR> <BR> 3. Declaration from Joint Managing Directors w.r.t. Audit Report with unmodified opinion to the Audited Financial Results for the financial year ended 31st March, 2022.",
            "news_id": "8964f12c-fb0f-44f1-a8e8-6c35e1a63d7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31aa99ae-e33a-4878-81c0-167fde603e7e.pdf",
            "news_date": "2022-05-14 16:11:05",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We are submitting herewith the Transcript of Earnings Audio Conference Call held on 7th February, 2022 at 4.00 PM wherein Financial Performance for Quarter and nine months ended 31st December, 2021 was discussed.",
            "news_id": "fa8186b4-046e-43bc-904a-5ef101285a27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=831f6176-497a-4b33-a016-db2a96cc2446.pdf",
            "news_date": "2022-02-09 15:44:40",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company''s revised Investor Presentation for the month of February, 2022.",
            "news_id": "9ceca42c-75ed-4a2d-b3af-d5c5ae88fbc6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd6b198a-1376-40ab-ba10-9a055bb060a2.pdf",
            "news_date": "2022-02-07 18:06:42",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company''s Investor Presentation for the month of February, 2022.",
            "news_id": "6e88a1db-456d-4dc3-bc0b-e2520eff7a86",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d40c5d3-903c-41d1-8e86-6263cddf9c50.pdf",
            "news_date": "2022-02-07 15:54:13",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter & Nine Months Ended December 31, 2021 Along With Limited Review Report.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Unaudited Financial Results for the quarter & nine months ended December 31, 2021; and  <BR> <BR> 2. Limited Review Report for the quarter ended December 31, 2021.<BR>",
            "news_id": "8dff668d-da05-4589-8c44-dffcce7bcb15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00b5ace2-66ae-4ab5-a0aa-4d393bb4118d.pdf",
            "news_date": "2022-02-04 17:11:47",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2021",
            "news_body": "Pursuant to the provisions of 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of related party transactions on a consolidated basis for the half year ended September 30, 2021.",
            "news_id": "6e479b31-1466-40c4-8718-8f30f6898b8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=349eb213-cd17-41fe-a7cd-c8c881b25a57.pdf",
            "news_date": "2021-11-20 16:13:06",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We are submitting herewith the Transcript of Earnings Audio Conference Call held on 16th November, 2021 at 4.00 PM wherein Financial Performance for Quarter ended 30th September, 2021 was discussed.",
            "news_id": "5942ddb4-5be8-40bc-bb57-0b803a9f059a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54ed19a8-555d-48ea-8e85-8cff1d5431dc.pdf",
            "news_date": "2021-11-18 14:51:01",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company's Investor Presentation for the month of November, 2021.",
            "news_id": "35e406ed-35cf-4a49-834b-656b2d31429d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554ac8b3-8cda-4509-a652-ecd0661ca25e.pdf",
            "news_date": "2021-11-12 17:54:53",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter & Half Year Ended September 30, 2021 Along With Limited Review Report",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> 1. Unaudited Financial Results for the quarter & half year ended September 30, 2021; and<BR> 2. Limited Review Report for the quarter ended September 30, 2021.",
            "news_id": "77de18fc-3207-4aef-9d1d-3cb7d23a412b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88f07585-da07-4334-839a-e3e065ffcfcc.pdf",
            "news_date": "2021-11-10 16:00:41",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We are submitting herewith the Transcript of Earnings Audio Conference Call held on 10th August, 2021 at 4.30 PM wherein Financial Performance for Quarter ended 30th June, 2021 was discussed",
            "news_id": "aa38b6a5-b8f7-479c-bbbb-0ab71ed796c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=471c3a21-c171-4907-be1a-f9eff0dce9d7.pdf",
            "news_date": "2021-08-12 14:42:57",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company's Investor Presentation for the month of August, 2021.",
            "news_id": "17deecd8-4114-485b-908f-d0d0c589ebed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8331772d-19c2-4f3e-bafa-d0976140f7f0.pdf",
            "news_date": "2021-08-09 18:35:21",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter Ended              June 30, 2021 Along With Limited Review Report",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Unaudited Financial Results for the quarter ended June 30, 2021; and<BR>  <BR> 2. Limited Review Report for the quarter ended June 30, 2021.<BR>",
            "news_id": "6f952635-86dc-4f87-bc64-d0ffe4d3fa1a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc6c5950-2f5a-4c06-975e-fbc504a7cada.pdf",
            "news_date": "2021-08-06 16:15:59",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2021",
            "news_body": "Pursuant to the provisions of 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of related party transactions on a consolidated basis for the half year ended March 31, 2021.",
            "news_id": "11697c39-95e4-415c-9f8f-5cd94774a6c3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3adfc532-a48c-4522-9ea5-18481f45f1d6.pdf",
            "news_date": "2021-06-02 15:10:04",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company's Investor Presentation for the month of May, 2021.",
            "news_id": "f16f4f7f-9447-48fa-af52-73c57456a95b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7044444-dc02-4119-b52c-b23aca99c3ac.pdf",
            "news_date": "2021-05-25 13:14:10",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results Along With Auditor'S Report For The Year Ended March 31, 2021 & Declaration",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Audited Financial Results for the quarter & year ended March 31, 2021; and<BR> <BR> 2. Auditor's Report on quarterly financial results and year to date results for the year ended 31st March, 2021; and <BR> <BR> 3. Declaration from Joint Managing Directors w.r.t. Audit Report with unmodified opinion to the Audited Financial Results for the financial year ended 31st March, 2021.<BR>",
            "news_id": "46997894-4495-4fa8-8571-9ee70d358f37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37c30e9e-0c28-42f7-b162-842dd664d952.pdf",
            "news_date": "2021-05-21 17:14:06",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Earnings Video Conference Call held on 17th February, 2021 at 4.00 PM to discuss the Financial Performance for Quarter & Nine months 31st December, 2020.",
            "news_id": "9e95b98c-1333-4e30-803f-172ab40cddd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b868232c-3042-434d-a145-5d52a66e9cda.pdf",
            "news_date": "2021-02-19 14:29:55",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}